Answer
Bone marrow suppression is very common with systemic mitomycin treatment, occurring in up to 65% of patients.
Sources for this answer
- Mitomycin medac, 40 mg, Powder and solvent for intravesical solutionmedac Pharma LLP · emc · SmPC §4.8 Undesirable effects · Version 9Document updated
Sources checked